Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DANAHER CORP /DE/DHR · Entity 2871 | EVP | October 23, 2020 | October 27, 2020 |
| Fortive CorpFTV · Entity 3303 | Director | June 09, 2026 | June 11, 2026 |
| Veralto CorpVLTO · Entity 3203 | Director | July 15, 2026 | July 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DANAHER CORP /DE/
Report date October 23, 2020 · Filed October 27, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 92,683 |
Ending reported balance
After 2020-10-23 transaction · row 8
8 source rows · reconciled sequenceRow 1 · 2020-10-23 · Exercise / conversion · Acquired 37,478 · Balance 130,161 Row 2 · 2020-10-23 · Sale · Disposed 14,615 · Balance 115,546 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.00 to $232.98, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. Row 3 · 2020-10-23 · Sale · Disposed 4,163 · Balance 111,383 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.00 to $233.99, inclusive. Row 4 · 2020-10-23 · Sale · Disposed 8,501 · Balance 102,882 F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.02 to $235.00, inclusive. Row 5 · 2020-10-23 · Sale · Disposed 8,629 · Balance 94,253 F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.03 to $235.74, inclusive. Row 6 · 2020-10-23 · Sale · Disposed 1,570 · Balance 92,683 F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.04 to $236.38, inclusive. Row 7 · 2020-10-23 · Exercise / conversion · Acquired 16,924 · Balance 109,607 Row 8 · 2020-10-23 · Sale · Disposed 16,924 · Balance 92,683 F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.95 to $232.32, inclusive. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $65.83 · Expires 2025-02-24 | Direct | 16,924 |
Reported balance
After 2020-10-23 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2020-10-23 · Exercise / conversion · Disposed 37,478 · Balance 16,924 F7: One half of the options granted became exercisable on each of the fourth and fifth anniversaries of the grant date, which was February 24, 2015. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $65.83 · Expires 2025-02-24 | Direct | 0 |
Reported balance
After 2020-10-23 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2020-10-23 · Exercise / conversion · Disposed 16,924 · Balance 0 F7: One half of the options granted became exercisable on each of the fourth and fifth anniversaries of the grant date, which was February 24, 2015. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 2,543 |
Reported balance
Holding disclosure · report date 2020-10-23 · row 9
Holding and transaction disclosures are not merged.
1 source rowRow 9 · Balance 2,543 |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 1,000 |
Reported balance
Holding disclosure · report date 2020-10-23 · row 10
Holding and transaction disclosures are not merged.
1 source rowRow 10 · Balance 1,000 |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 38,804 |
Reported balance
Holding disclosure · report date 2020-10-23 · row 11
Holding and transaction disclosures are not merged.
1 source rowRow 11 · Balance 38,804 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.00 to $232.98, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.00 to $233.99, inclusive.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.02 to $235.00, inclusive.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.03 to $235.74, inclusive.
F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.04 to $236.38, inclusive.
F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.95 to $232.32, inclusive.
F7: One half of the options granted became exercisable on each of the fourth and fifth anniversaries of the grant date, which was February 24, 2015.
Fortive Corp
Report date June 09, 2026 · Filed June 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 53,122 |
Reported balance
After 2026-06-09 transaction · row 1
1 source rowRow 1 · 2026-06-09 · Grant · Acquired 3,350 · Balance 53,122 F1: On June 9, 2026, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2027 annual meeting of the stockholders, but, based on the election of the Reporting Person, the underlying shares will not be issued until the earlier of the Reporting Person's death or the first anniversary following the Reporting Person's retirement from the Board of Directors of the Issuer. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 1,721 |
Reported balance
Holding disclosure · report date 2026-06-09 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,721 |
| Common StockSEC Table I · non-derivative | IndirectThrough Irrevocable Trusts | 75 |
Reported balance
Holding disclosure · report date 2026-06-09 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 75 |
Filing footnotes · ownership attribution and instrument terms
F1: On June 9, 2026, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2027 annual meeting of the stockholders, but, based on the election of the Reporting Person, the underlying shares will not be issued until the earlier of the Reporting Person's death or the first anniversary following the Reporting Person's retirement from the Board of Directors of the Issuer.
Veralto Corp
Report date July 15, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,509 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 1,099 · Balance 18,509 F1: Reflects a grant of restricted stock units that vest on the earlier of the first anniversary of the grant date or the date of (and immediately prior to) the next annual meeting of Veralto's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first date of the seventh month following the director's retirement from Veralto's Board. |
| Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $91.00 · Expires 2036-07-15 | Direct | 9,413 |
Reported balance
After 2026-07-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-15 · Grant · Acquired 3,553 · Balance 9,413 F2: The options granted to our non-employee directors will be fully vested as of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a grant of restricted stock units that vest on the earlier of the first anniversary of the grant date or the date of (and immediately prior to) the next annual meeting of Veralto's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first date of the seventh month following the director's retirement from Veralto's Board.
F2: The options granted to our non-employee directors will be fully vested as of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 22, 2003 Filed Jul 24, 2003 20:41 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Exercise / conversionCommon Stock | 11,000 | $11.75 | $129,250.00 |
DisclosureSEC source: 0001205260-03-000001 · edgar.xml · nonDerivative · entry 1 COMAS DANIEL L · CIK 0001205260 · VP -- Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,132 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.